Sagar B. Kudchodkar, Ph.D.
Affiliations: | 2007 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Virology Biology, Cell BiologyGoogle:
"Sagar Kudchodkar"Parents
Sign in to add mentor| James C. Alwine | grad student | 2007 | Penn | |
| (Dealing with stress: Human cytomegalovirus maintains translation in cells under adverse conditions.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tebas P, Roberts CC, Muthumani K, et al. (2021) Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine. The New England Journal of Medicine. 385: e35 |
| Choi H, Kudchodkar SB, Ho M, et al. (2020) A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus. Plos Neglected Tropical Diseases. 14: e0008788 |
| Zankharia US, Kudchodkar S, Khoshnejad M, et al. (2020) Neutralization of hepatitis B virus by a novel DNA-encoded monoclonal antibody. Human Vaccines & Immunotherapeutics. 1-9 |
| Choi H, Kudchodkar SB, Reuschel EL, et al. (2019) Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge. Human Vaccines & Immunotherapeutics. 1-12 |
| Modjarrad K, Roberts CC, Mills KT, et al. (2019) Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial. The Lancet. Infectious Diseases |
| Esquivel RN, Patel A, Kudchodkar SB, et al. (2019) In Vivo Delivery of a DNA-Encoded Monoclonal Antibody Protects Non-human Primates against Zika Virus. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Choi H, Kudchodkar SB, Reuschel EL, et al. (2019) Protective immunity by an engineered DNA vaccine for Mayaro virus. Plos Neglected Tropical Diseases. 13: e0007042 |
| Tang L, Zheng Y, Melo MB, et al. (2018) Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery. Nature Biotechnology |
| Kudchodkar SB, Choi H, Reuschel EL, et al. (2018) Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus. Microbes and Infection |
| Tebas P, Roberts CC, Muthumani K, et al. (2017) Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine - Preliminary Report. The New England Journal of Medicine |